Discovery of a Novel Inhibitor of the Protein Tyrosine Phosphatase Shp2
Citations Over TimeTop 17% of 2015 papers
Abstract
Shp2 is a ubiquitously expressed protein tyrosine phosphatase (PTP) related to adult acute myelogenous leukemia and human solid tumors. In this report, we describe identification of a potent Shp2 inhibitor, Fumosorinone (Fumos) from entomogenous fungi, which shows selective inhibition of Shp2 over other tested PTPs. Using a surface plasmon resonance analysis, we further confirmed the physical interaction between Shp2 and Fumos. Fumos inhibits Shp2-dependent activation of the Ras/ERK signal pathway downstream of EGFR, and interrupts EGF-induced Gab1-Shp2 association. As expected, Fumos shows little effects on the Shp2-independent ERK1/2 activation induced by PMA or oncogenic Ras. Furthermore, Fumos down-regulates Src activation, inhibits phosphorylation of Paxillin and prevents tumor cell invasion. These results suggest that Fumos can inhibit Shp2-dependent cell signaling in human cells and has a potential for treatment of Shp2-associated diseases.
Related Papers
- → Combined expression of the non-receptor protein tyrosine kinases FAK and Src in primary colorectal cancer is associated with tumor recurrence and metastasis formation(2008)21 cited
- → FAK regulates tyrosine phosphorylation of CAS, paxillin, and PYK2 in cells expressing v‐Src, but is not a critical determinant of v‐Src transformation(2001)52 cited
- → Phosphorylation of p125FAK and paxillin focal adhesion proteins in src‐transformed cells with different metastatic capacity(1999)29 cited
- → Κλινική σημασία της έκφρασης των πρωτεϊνών FAK, Src και Paxillin σε ηπατικές μεταστάσεις από ορθοκολικό καρκίνο(2020)
- → Η έκφραση της Focal Adhesion Kinase, Src kinase και Paxillin σε κυτταρολογικό υλικό ασθενών με νευρoβλάστωμα(2015)